Tenero D[au] - Search Results

Year	Number of Results
1988	1
1989	2
1990	3
1997	2
1998	6
1999	4
2000	1
2002	1
2006	4
2007	2
2013	2
2014	1
2015	1
2017	1
2018	3
2019	4
2023	0

1

The challenge of antimicrobial resistance: new regulatory tools to support product development.

Tomayko JF, Rex JH, Tenero DM, Goldberger M, Eisenstein BI. Tomayko JF, et al. Among authors: tenero dm. Clin Pharmacol Ther. 2014 Aug;96(2):166-8. doi: 10.1038/clpt.2014.107. Epub 2014 May 13. Clin Pharmacol Ther. 2014. PMID: 24823890 Review.

2

Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial.

Thakkar N, Green JA, Koh GCKW, Duparc S, Tenero D, Goyal N. Thakkar N, et al. Among authors: tenero d. Antimicrob Agents Chemother. 2018 Oct 24;62(11):e00711-18. doi: 10.1128/AAC.00711-18. Print 2018 Nov. Antimicrob Agents Chemother. 2018. PMID: 30201820 Free PMC article.

3

Pharmacokinetic properties of a new controlled-release formulation of carvedilol.

Tenero DM, Henderson LS, Baidoo CA, Harter AH, Campanile AM, Danoff TM, Boyle D. Tenero DM, et al. Am J Cardiol. 2006 Oct 2;98(7A):5L-16L. doi: 10.1016/j.amjcard.2006.07.014. Epub 2006 Aug 28. Am J Cardiol. 2006. PMID: 17023227 Review.

4

A review of eprosartan pharmacokinetic and pharmacodynamic drug interaction studies.

Blum RA, Kazierad DJ, Tenero DM. Blum RA, et al. Among authors: tenero dm. Pharmacotherapy. 1999 Apr;19(4 Pt 2):79S-85S. doi: 10.1592/phco.19.7.79s.30948. Pharmacotherapy. 1999. PMID: 10213526 Review.

5

Dilevalol: an overview of its clinical pharmacology and therapeutic use in hypertension.

Lalonde RL, Tenero DM, Kazierad DJ. Lalonde RL, et al. Among authors: tenero dm. Pharmacotherapy. 1990;10(1):15-28. Pharmacotherapy. 1990. PMID: 2179899 Review.

6

Pharmacokinetics of eprosartan in healthy subjects, patients with hypertension, and special populations.

Bottorff MB, Tenero DM. Bottorff MB, et al. Among authors: tenero dm. Pharmacotherapy. 1999 Apr;19(4 Pt 2):73S-78S. doi: 10.1592/phco.19.7.73s.30946. Pharmacotherapy. 1999. PMID: 10213525 Review.

7

Pharmacokinetics, Safety, and Tolerability Evaluation of Single and Multiple Doses of GSK3342830 in Healthy Volunteers.

Tenero D, Farinola N, Berkowitz EM, Tiffany CA, Qian Y, Xue Z, Raychaudhuri A, Gardiner DF. Tenero D, et al. Clin Pharmacol Drug Dev. 2019 Aug;8(6):754-764. doi: 10.1002/cpdd.637. Epub 2018 Dec 10. Clin Pharmacol Drug Dev. 2019. PMID: 30536589 Clinical Trial.

8

Pharmacokinetics and pharmacodynamics of dilevalol.

Tenero DM, Bottorff MB, Given BD, Kramer WG, Affrime MB, Patrick JE, Lalonde RL. Tenero DM, et al. Clin Pharmacol Ther. 1989 Dec;46(6):648-56. doi: 10.1038/clpt.1989.201. Clin Pharmacol Ther. 1989. PMID: 2598569

9

Intrapulmonary pharmacokinetics of GSK2251052 in healthy volunteers.

Tenero D, Bowers G, Rodvold KA, Patel A, Kurtinecz M, Dumont E, Tomayko J, Patel P. Tenero D, et al. Antimicrob Agents Chemother. 2013 Jul;57(7):3334-9. doi: 10.1128/AAC.02483-12. Epub 2013 May 6. Antimicrob Agents Chemother. 2013. PMID: 23650164 Free PMC article. Clinical Trial.

10

Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Cefepime in an In Vitro Infection Model.

VanScoy BD, Tenero D, Turner S, Livermore DM, McCauley J, Conde H, Bhavnani SM, Rubino CM, Ambrose PG. VanScoy BD, et al. Among authors: tenero d. Antimicrob Agents Chemother. 2017 Nov 22;61(12):e01052-17. doi: 10.1128/AAC.01052-17. Print 2017 Dec. Antimicrob Agents Chemother. 2017. PMID: 28947475 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

37 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

37 results

Results by year